![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Allos Therapeutics, Inc. (MM) | NASDAQ:ALTH | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.83 | 0 | 01:00:00 |
(Name
of Issuer)
Common
Stock, par value $0.001 per share
|
||
(Title
of Class of Securities)
|
||
019777101
|
||
(CUSIP
Number)
|
||
December
31, 2007
|
||
(Date
of Event which Requires Filing of this
Statement)
|
CUSIP No. 019777101 |
|
|
1 |
Names of Reporting Persons
I.R.S. Identification Nos. of Above Persons (ENTITIES ONLY). |
|
Felix
J. Baker
|
||
2 | Check the Appropriate Box if Member of a Group (See Instructions) | |
(a)
o
|
||
(b)
o
|
||
3 | SEC Use Only | |
4 | Citizenship or Place of Organization | |
United
States
|
|
5 | Sole Voting Power |
|
||
|
-0-
|
|
Number
of
|
6 | Shared Voting Power |
Shares
|
||
Beneficially
|
8,741,480
|
|
Owned
by
|
7 | Sole Dispositive Power |
Each
Reporting
|
||
Person
With
|
-0-
|
|
|
8 | Shared Dispositive Power |
|
||
8,741,480
|
9 |
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
8,741,480
|
||
10 |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
|
o
|
||
11 |
Percent
of Class Represented by Amount in Row (9)
|
|
13.1% | ||
12 |
Type
of Reporting Person (See Instructions)
|
|
IN |
CUSIP No. 019777101 |
|
|
1 |
Names of Reporting Persons
I.R.S. Identification Nos. of Above Persons (ENTITIES ONLY). |
|
Julian
C. Baker
|
||
2 | Check the Appropriate Box if Member of a Group (See Instructions) | |
(a)
o
|
||
(b)
o
|
||
3 | SEC Use Only | |
4 | Citizenship or Place of Organization | |
United
States
|
|
5 | Sole Voting Power |
|
||
|
-0-
|
|
Number
of
|
6 | Shared Voting Power |
Shares
|
||
Beneficially
|
8,741,480
|
|
Owned
by
|
7 | Sole Dispositive Power |
Each
Reporting
|
||
Person
With
|
-0-
|
|
|
8 | Shared Dispositive Power |
|
||
8,741,480
|
9 |
Aggregate
Amount Beneficially Owned by Each Reporting Person
|
|
8,741,480
|
||
10 |
Check
if the Aggregate Amount in Row (9) Excludes Certain Shares (See
Instructions)
|
|
o
|
||
11 |
Percent
of Class Represented by Amount in Row (9)
|
|
13.1% | ||
12 |
Type
of Reporting Person (See Instructions)
|
|
IN |
Name
|
Business
Address
|
Felix
J. Baker
|
667
Madison Avenue
New
York, NY 10065
|
Julian
C. Baker
|
667
Madison Avenue
New
York, NY 10065
|
Item
3.
|
If
this statement is filed pursuant to §§240.13d-1(b) or (c), check whether
the person filing is a:
N/A
|
Name
|
Number
of Shares
|
Percent
of Class
Outstanding
|
|||||
Baker
Bros. Investments, L.P.
|
75,118
|
0.1
|
%
|
||||
Baker
Bros. Investments II, L.P.
|
114,899
|
0.2
|
%
|
||||
Baker
Biotech Fund I, L.P.
|
2,251,147
|
3.4
|
%
|
||||
Baker
Brothers Life Sciences, L.P.
|
6,011,855
|
9.0
|
%
|
||||
14159,
L.P.
|
201,087
|
0.3
|
%
|
||||
Baker/Tisch
Investments, L.P.
|
87,374
|
0.1
|
%
|
||||
Total
|
8,741,480
|
13.1
|
%
|
/s/
Felix J. Baker
|
Felix
J. Baker
|
/s/
Julian C. Baker
|
Julian
C. Baker
|
/s/
Felix J. Baker
|
Felix
J. Baker
|
/s/
Julian C. Baker
|
Julian
C. Baker
|
1 Year Allos Therapeutics, Inc. (MM) Chart |
1 Month Allos Therapeutics, Inc. (MM) Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions